Madrigal Pharmaceuticals ... (MDGL)

MDGL trades at $443.01, 47.7% above the near-term max pain of $300 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($300-$450), signaling increased put positioning or downside protection. Key magnetic zone at 400 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for MDGL shows a downward trend from 450 to 300, indicating bearish sentiment or hedging activity. The 40% spread signals divergent expectations across timeframes. Most levels below 443.01 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.